Mode
Text Size
Log in / Sign up

Team STEPPS discharge planning improves readiness and quality of life in hospitalized IBD patients

Team STEPPS discharge planning improves readiness and quality of life in hospitalized IBD patients
Photo by Clayton Robbins / Unsplash
Key Takeaway
Consider that Team STEPPS discharge planning may improve readiness and quality of life in hospitalized IBD, but confirm in larger trials.

This randomized controlled trial evaluated a structured Team STEPPS-based discharge planning program in 90 inpatients with inflammatory bowel disease in a hospital setting. Participants were assigned to the intervention or to standard care, with outcomes assessed during a 30-day follow-up period.

The primary outcome, discharge readiness, was significantly higher in the intervention group (103.0 ± 7.3) than in the control group (94.9 ± 4.7; P < 0.001). The quality of discharge teaching was also significantly higher in the intervention group (183.6 ± 6.4) compared with control (172.7 ± 5.0; P < 0.001). For health-related quality of life, the intervention group demonstrated a greater magnitude of improvement, with an incremental benefit of 9.2 points (95% CI: 5.7–12.7; P < 0.001).

Adverse events, serious adverse events, discontinuations, and overall tolerability were not reported. The study was conducted in a single hospital, which may limit generalizability. Practice relevance and funding or conflicts were not reported.

While the results are statistically significant, they derive from a single-center trial. Clinicians should interpret these findings as promising evidence that a Team STEPPS-based discharge program may enhance readiness and quality of life, with confirmation in larger, multicenter studies needed before widespread adoption.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BackgroundThe transition from hospital to home is a high-risk period for patients with Inflammatory Bowel Disease (IBD). This study aimed to develop and preliminarily validate a structured discharge planning program for patients with IBD by applying the Team STEPPS framework.MethodsThis study employed a sequential two-phase, mixed-methods design. First, a Team STEPPS-based discharge planning program was rigorously developed using Delphi method between August and October 2023. Subsequently, a randomized controlled trial was conducted from October 2023 to March 2024 to validate the program. Ninety eligible inpatients were randomly assigned to an intervention group (n = 45) receiving the structured Team STEPPS program or a control group (n = 45) receiving standard care. The primary outcome was discharge readiness, assessed at the time of discharge. Secondary outcomes included the quality of discharge teaching, measured at discharge, and health-related quality of life, evaluated at baseline, discharge, and 30-day follow-up. Longitudinal outcomes analyzed via linear mixed-effects models.ResultsAll 90 enrolled participants completed the study. The Delphi process successfully achieved expert consensus, resulting in a structured discharge program with all items meeting predefined criteria (mean importance ≥ 4.0, coefficient of variation ≤ 0.25). In the subsequent randomized controlled trial, baseline characteristics were well-balanced. At discharge, the intervention group exhibited statistically superior outcomes, including significantly higher discharge readiness (103.0 ± 7.3 vs. 94.9 ± 4.7, P < 0.001) and quality of discharge teaching scores (183.6 ± 6.4 vs. 172.7 ± 5.0, P < 0.001). Longitudinal analysis of health-related quality of life revealed a significant group-by-time interaction effect (P < 0.001), with the intervention group demonstrating a greater magnitude of improvement. The model estimated an incremental benefit of the intervention of 9.2 points (95% CI: 5.7–12.7) at the 30-day follow-up compared to standard care.ConclusionA Team STEPPS-based discharge planning program was successfully developed and shown to be effective, significantly improving discharge readiness, the quality of discharge teaching, and health-related quality of life in patients with IBD.Clinical trial registrationhttps://www.chictr.org.cn/index.html, identifier ChiCTR2501113716.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.